The nickel ion bioavailability model of the carcinogenic potential of nickel-containing substances in the lung

Critical Reviews in Toxicology

Volumn 41, Issue 2, 2011, Pages 142-174

  Goodman, Julie E ^a   Prueitt, Robyn L ^a   Thakali, Sagar ^a   Oller, Adriana R ^b  

^a GRADIENT   (United States)

^b NiPERA   (United States)

Author keywords

Mechanism of action; metals; respiratory cancer; risk assessment; tumor induction; weight of evidence

Indexed keywords

NICKEL; URANIUM;

BIOAVAILABILITY; CANCER RISK; CARCINOGENICITY; CLEARANCE; DUST; ELECTROPLATING INDUSTRY; ENDOCYTOSIS; GRINDING; HUMAN; ION TRANSPORT; LUNG CANCER; LUNG TOXICITY; MINING; NONHUMAN; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; RESPIRATORY EPITHELIUM; REVIEW; RISK ASSESSMENT;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; BIOLOGICAL AVAILABILITY; CARCINOGENS, ENVIRONMENTAL; HUMANS; INHALATION EXPOSURE; LUNG; NICKEL; OCCUPATIONAL DISEASES; RESPIRATORY MUCOSA;

ANIMALIA; MARTES;

EID: 79551623867     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.531460     Document Type: Review

References (128)

1. Abbracchio MP, Evans RM, Heck JD, Cantoni O, Costa M. (1982a). Te regulation of ionic nickel uptake and cytotoxicity by specifc amino acids and serum components. Biol Trace Elements Res 4:289-301.
2. Abbracchio MP, Heck JD, Costa M. (1981). Diferences in surface properties of amorphous and crystalline metal sulfdes may explain their toxicological potency. Chemosphere 10:897-908.
3. Abbracchio MP, Heck JD, Costa M. (1982b). Te phagocytosis and transforming activity of crystalline metal sulfde particles are related to their negative surface charge. Carcinogen 3(2):175-180.
4. Abbracchio MP, Simmons-Hansen J, Costa M. (1982c). Cytoplasmic dissolution of phagocytized crystalline nickel sulfde particles: A prerequisite for nuclear uptake of nickel. J Toxicol Environ Health 9(4):663-676.
5. Andersen A, Berge SR, Engeland A, Norseth T. (1996). Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refnery workers. Occup Environ Med 53(10):708-713.
6. Anttila A, Pukkala E, Aitio A, Rantanen T, Karjalainen S. (1998). Update of cancer incidence among workers at a copper/nickel smelter and nickel refnery. Int Arch Occup Environ Health 71:245-250.
7. Arena VC, Costantino JP, Sussman NB, Redmond CK. (1999). Issues and fndings in the evaluation of occupational risk among women high nickel alloys workers. Am J Ind Med 36:114-121.
8. Arena VC, Sussman NB, Redmond CK, Costantino JP, Trauth JM. (1998). Using alternative comparison populations to assess occupation-related mortality risk: Results for the high nickel alloys workers cohort. J Occup Environ Med 40:907-916.
9. Benson JM, Barr EB, Bechtold WE, Cheng Y-S. (1994). Fate of inhaled nickel oxide and nickel subsulfde in F344/N rats. Inhal Toxicol 6:167-183.
10. Benson JM, Brooks AL, Henderson RF. (1992). Comparative in vitro cytotoxicity of nickel compounds to pulmonary alveolar macrophages and rat lung epithelial cells. In: Nieboer E, Nriagu JO, eds. Nickel and Human Health: Current Perspectives. New York: John Wiley & Sons, Inc., 319-330.
11. Benson JM, Burt DG, Cheng YS, Hahn FF, Haley PJ, Henderson RF, Hobbs CH, Pickrell JA, Dunnick JK. (1989). Biochemical responses of rat and mouse lung to inhaled nickel compounds. Toxicology 57(3):255-266.
12. Benson JM, Chang IY, Cheng YS, Hahn FF, Kennedy CH, Barr EB, Maples KR, Snipes MB. (1995a). Particle clearance and histopathology in lungs of F344/N rats and B6C3F1 mice inhaling nickel oxide or nickel sulfate. Fundam Appl Toxicol 28:232-244.
13. Benson JM, Cheng YS, Eidson AF, Hahn FF, Henderson RF, Pickrell JA. (1995c). Pulmonary toxicity of nickel subsulfde in F344/N rats exposed for 1-22 days. Toxicology 103:9-22.
14. Benson JM, Henderson RF, McClellan RO, Hanson RL, Rebar AH. (1986). Comparative acute toxicity of four nickel compounds to F344 rat lung. Fundam Appl Toxicol 7(2):340-347.
15. Benson JM, Maples KR, Hahn FF, Chang LY, Cheng YS. (1995b). Final Report. Report to Nickel Producers Environmental Research Association, Inc., Durham, NC.
16. Benson JM, March TH, Hahn F F, Seagrave J, Divine KK, Belinsky SA. (2002). Final Report for Short-Term Inhalation Study with Nickel Compounds. Report to Nickel Producers' Producers' Environmental Research Association, Inc., Durham, NC., 93 p., June.
17. Beyersmann D, Hartwig A. (2008). Carcinogenic metal compounds: Recent insight into molecular and cellular mechanisms. Arch Toxicol 82:493-512.
18. Bolt HM, Huici-Montagud A. (2008). Strategy of the scientifc committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens. Arch Toxicol 82(1):61-64.
19. Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36(10):781-792. (Pubitemid 44800328)
20. California Air Resources Board (CARB). (1991). Initial Statement of Reasons for Rulemaking: Proposed Identifcation of Nickel as a Toxic Air Contaminant: Technical Support Document, Part B. Sacramento, CA: California Dept. of Health Services. 159 pp., July.
21. Carvalho SMM, Ziemer PL. (1982). Distribution and clearance of 63Ni administered as 63NiCl2 in the rat: Intratracheal study. Arch Environ Contam Toxicol 11:245-248.
22. Costa M. (1983). Approaches toward studying genotoxicity and potential carcinogenicity of metal compounds in vitro. J Parenter Sci Technol 37(6):231-237.
23. Costa M; Abbracchio MP, Simmons-Hansen J. (1981a). Factors infuencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. Toxicol Appl Pharmacol 60(2):313-323.
24. Costa M, Davidson TL, Chen H, Ke Q, Zhang P, Yan Y, Huang C, Kluz T. (2005). Nickel carcinogenesis: Epigenetics and hypoxia signaling. Mutat Res 592(1-2):79-88.
25. Costa M, Heck JD, Robison SH. (1982). Selective phagocytosis of crystalline metal sulfde particles and DNA strand breaks as a mechanism for the induction of cellular transformation. Cancer Res 42(7):2757-2763.
26. Costa M, Heck JD. (1982). Specifc nickel compounds as carcinogens. Trends Pharmacol Sci 3:408-410.
27. Costa M, Mollenhauer HH. (1980a). Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. Science 209(4455):515-517.
28. Costa M, Mollenhauer HH. (1980b). Phagocytosis of nickel subsulfde particles during the early stages of neoplastic transformation in tissue culture. Cancer Res 40(8 Pt 1):2688-2694.
29. Costa M, Nye JS, Sunderman FW, Allpass PR, Gondos B. (1979). Induction of sarcomas in nude mice by implantation of Syrian hamster fetal cells exposed in vitro to nickel subsulfde. Cancer Res 39:3591-3597.
30. Costa M, Simmons-Hansen J, Bedrossian CW, Bonura J, Caprioli RM. (1981b). Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture. Cancer Res 41(7):2868-2876. (Pubitemid 11071826)
31. Costa M, Yan Y, Zhao D, Salnikow K. (2003). Molecular mechanisms of nickel carcinogenesis: Gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling. J Environ Monit 5:222-223.
32. Cox, JE, Doll R, Scott WA, Smith S. (1981). Mortality of nickel workers: Experience of men working with metallic nickel. Br J Ind Med 38(3):235-239.
33. Cragle DL, Hollis DR, Newport TH. (1984). A retrospective cohort mortality study among workers occupationally exposed to metallic nickel powder at the Oak Ridge Gaseous Difusion Plant. IARC Scientifc Publication No. 53. In: Sunderman FW, ed. Nickel in the Human Environment: Proceedings of a Joint Symposium held at IARC, Lyon, France, 8-11 March 1983. IARC Scientifc Publication No. 53. Lyon: International Agency for Research on Cancer (IARC), Lyon, 57-63.
34. Doll R. (1958). Cancer of the lung and nose in nickel workers. Br J Ind Med 15:217-223.
35. Dunnick JK, Benson JM, Hobbs CH, Hahn FF, Cheng YS, Edison AF. (1988). Comparative toxicity of nickel oxide, nickel sulfate hexahydrate, and nickel subsulfde after 12 days of inhalation exposure to F344/N rats and B6C3F1 mice. Toxicology 50(2):145-156.
36. Dunnick JK, Elwell MR, Benson JM, Hobbs CH, Hahn FF, Haly PJ, Cheng YS, Edison A F. (1989). Lung toxicity after 13-week inhalation exposure to nickel oxide, nickel subsulfde, or nickel sulfate hexahydrate in F344/N rats and B6C3F1 mice. Fundam Appl Toxicol 12(3):584-594.
37. Dunnick JK, Elwell MR, Radovsky AE, Benson JM, Hahn FF, Nikula KJ, Barr EB, Hobbs CH. (1995). Comparative carcinogenic efects of nickel subsulfde, nickel oxide, or nickel sulfate hexahydrate on chronic exposures in the lung. Cancer Res 55:5251-5256.
38. Easton DF, Peto J, Morgan LG, Metcalfe LP, Usher V, Doll R. (1992). Respiratory cancer mortality in Welsh nickel refners: Which nickel compounds are responsible? In: Nieboer E, Nriagu JO, eds. Nickel and Human Health: Perspectives. New York: John Wiley & Sons, Inc., 603-619.
39. Edelman D, Roggli V. (1989). Te accumulation of nickel in human lungs. Environ Health Perspect 81:221-224.
40. Egedahl R, Carpenter M, Lundell D. (2001). Mortality experience among employees at a hydrometallurgical nickel refnery and fertiliser complex in Fort Saskatchewan, Alberta (1954-95). Occup Environ Med 58(11):711-715.
41. Egedahl RD, Collins MJ. (2009). Vital Status of Sherritt Nickel Refnery Workers (1954 - 2003). In: Budac J, Fraser R, Mihaylov I, Papangelakis V, Robinson D, eds. Hydrometallurgy of Nickel and Cobalt (Nickel and Cobalt Symposium, 48th Annual Conference of Metallurgists, held August 23- 26, 2009). Montreal, Canada. 689-699.
42. English J, Parker R, Sharma R, Oberg SD. (1981). Toxicokinetics of nickel in rats after intratracheal administration of a soluble and insoluble form. Am Ind Hyg Assoc J 42:486-492.
43. European Chemicals Agency (ECHA). (2008). Guidance on information requirements and chemical safety assessment. Part B: Hazard assessment. Version 1.1. May. [Online] Available at: http://guidance.echa.europa.eu/docs/guidance- document/information-requirements-part-b-en.pdf?vers = 20-10-08. Accessed on 04 October 2010.
44. Evans RM, Davies PJ, Costa M. (1982). Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfde particles in cultured mammalian cells. Cancer Res 42(7):2729-2735.
45. Finch GL, Fisher GL, Hayes TL. (1987). Te pulmonary efects and clearance of intratracheally instilled Ni3S2 and TiO2 in mice. Environ Res 42:83-93.
46. Fletcher GG, Rossetto FE, Turnbull JD, Nieboer E. (1994). Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds. Environ Health Perspect 102(Suppl. 3):69-79.
47. Funakoshi T, Inoue T, Shimada H, Kojima S. (1997). Te mechanisms of nickel uptake by rat primary hepatocyte cultures: Role of calcium channels. Toxicology 124(1):21-26.
48. Goldberg M, Goldberg P, Leclerc A, Chastang JF, Marne MJ, Dubourdieu D. (1994). A 10-year incidence survey of respiratory cancer and a case-control study within a cohort of nickel mining and refning workers in New Caledonia. Cancer Causes Control 5(1):15-25.
49. Goodman JE, Prueitt RL, Dodge DG, Takali S. (2009). Carcinogenicity assessment of water-soluble nickel compounds. Crit Rev Toxicol 39:365-417.
50. Grimsrud TK, Berge SR, Haldorsen T, Andersen A. (2002). Exposure to diferent forms of nickel and risk of lung cancer. Am J Epidemiol 156(12):1123-1132.
51. Grimsrud TK, Berge SR, Resman F, Norseth T., Andersen A. (2000). Assessment of historical exposures in a nickel refnery in Norway. Scand J Work Environ Health 26(4):338-345.
52. Grimsrud TK, Berge SR, Martinsen JI, Andersen A. (2003). Lung cancer incidence among Norwegian nickel-refnery workers 1953-2000. J Environ Monit 5:190-197. (Pubitemid 36503016)
53. Haber LT, Erdreicht L, Diamond GL, Maier AM, Ratney R, Zhao Q, Dourson ML. (2000). Hazard identifcation and dose response of inhaled nickel-soluble salts. Regul Toxicol Pharmacol 31: 210-230. (Pubitemid 30314348)
54. Hack CE, Covington TR, Lawrence G, Shipp AM, Gentry R, Yager J, Clewell HJ. (2007). A pharmacokinetic model of the intracellular dosimetry of inhaled nickel. J Toxicol Environ Health Part A 70:445-464.
55. Hansen KS, Lauritsen JM, Skytthe A. (1996). Cancer incidence among mild steel and stainless steel welders and other metal workers. Am J Ind Med 30(4):373-382.
56. Hansen K, Stern RM. (1983). In vitro toxicity and transformation potency of nickel compounds. Environ Health Perspect 51:223-226.
57. Hansen K, Stern RM. (1984). Toxicity and transformation potency of nickel compounds in BHK cells in vitro. IARC Scientifc Publication No. 53. In: Sunderman FW, ed. Nickel in the Human Environment: Proceedings of a Joint Symposium held at IARC, Lyon, France, 8-11 March 1983.
58. IARC Scientifc Publication No. 53. Lyon: International Agency for Research on Cancer (IARC), Lyon, 193-200.
59. Harnett PB, Robison SH, Swartzendruber DE, Costa M. (1982). Comparison of protein, RNA, and DNA binding and cell-cycle-specifc growth inhibitory efects of nickel compounds in cultured cells. Toxicol Appl Pharmacol 64(1):20-30.
60. Hayman PB, Goodgame DML, Snook RD. (1984). Studies of nickel absorption in rats using inductively coupled plasma atomic-emission spectrometry and liquid scintillation counting. Analyst 109:1593-1595.
61. Heck JD, Costa M. (1982). Surface reduction of amorphous Nickel sulfde particles potentiates their phagocytosis and subsequent induction of morphological transformation in Syrian hamster embryo cells. Cancer Lett 15(1):19-26.
62. Heim KE, Bates HK, Rush RE, Oller AR. (2007). Oral carcinogenicity study with nickel sulfate hexahydrate in Fischer 344 rats. Toxicol Appl Pharmacol 224(2):126-137.
63. Hengstler JG, Bogdanfy MS, Bolt HM, Oesch F. (2003). Challenging dogma: Tresholds for genotoxic carcinogens? Te case of vinyl acetate. Annu Rev Pharmacol Toxicol 43:485-520.
64. Hildebrand HF, Decaestecker AM, Arrouijal FZ, Martinez R. (1991). In vitro and in vivo uptake of nickel sulfdes by rat lymphocytes. Arch Toxicol 65(4):324-329.
65. Hildebrand H F, D'Hooghe MC, Shirali P, Bailly C, Kerckaert JP. (1990). Uptake and biological transformation of beta Nickel sulfde and alpha Nickel subsulfde by human embryonic pulmonary epithelial cells (L132) in culture. Carcinogen 11(11):1943-1950.
66. Hochrainer D, Oberdörster G, Mihm U. (1980). Generation of NiO aerosols for studying lung clearance of Ni and its efect on lung function. Gesellschaft fur Aerosolforschung 8:259-264.
67. Hong YC, Paik SR, Lee HJ, Lee HK, Jang SM. (1997). Magnesium inhibits nickel-induced genotoxicity and formation of reactive oxygen. Environ Health Perspect 105(7):744-748.
68. Hsieh T, Yu C, Oberdörster G. (1999). A dosimetry model of nickel compounds in the rat lung. Inhal Toxicol 11:229-248.
69. Hueper WC. (1958). Experimental studies in metal cancerigenesis: IX. Pulmonary lesions in guinea pigs and rats exposed to prolonged inhalation of powdered metallic nickel. AMA Arch Pathol 65:600-607.
70. Hueper WC, Payne WW. (1962). Experimental studies in metal carcinogenesis. Chromium, nickel, iron, arsenic. Arch Environ Health 5:445-462.
71. International Committee on Nickel Carcinogenesis in Man (ICNCM). (1990). Report of the International Committee on Nickel Carcinogenesis in Man. Scand J Work Environ Health 16(1):1-82.
72. Ishimatsu S, Kawamoto T, Matsuno K, Kodama Y. (1995). Distribution of various nickel compounds in rat organs after oral administration. Biol Trace Elem Res 49(1):43-52.
73. Jakobsson K, Mikoczy Z, Skerfving S. (1997). Deaths and tumours among workers grinding stainless steel: A follow up. Occup Environ Med 54(11):825-829.
74. Ke Q, Davidson T, Kluz T, Oller A, Costa M. (2007). Fluorescent tracking of nickel ions in human cultured cells. Toxicol Appl Pharmacol 219(1):18-23.
75. Kuehn K, Fraser CB, Sunderman FW. (1982). Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro. Carcinogenesis 3(3):321-326.
76. Landolph JR. (1994). Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fbroblasts by carcinogenic metal compounds. Environ Health Perspect 102(Suppl 3):119-125.
77. Løken AC. (1950). Lungecarcinom hos nikkelarbeidere. Tidsskr Nor Laegeforen 70:376-378.
78. ([In Norwegian)] Medinsky MA, Benson JM, Hobbs CH. (1987). Lung clearance and disposition of 63Ni in F344/N rats after intratracheal instillation of nickel sulfate solutions. Environ Res 43(1):168-178.
79. Menvielle G, Luce D, Févotte J, Bugel I, Salomon C, Goldberg P., Billon-Galland MA, Goldberg M. (2003). Occupational exposures and lung cancer in New Caledonia. Occup Environ Med 60(8):584-589.
80. Menzel D, Deal D, Tayyeb M, Wolpert RL, Boger JR, Shoaf CR, Sandy J, Wilkinson K, Francovitch RJ. (1987). Pharmacokinetic modeling of the lung burden from repeated inhalation of nickel aerosols. Toxicol Lett 38:33-43.
81. Miura T, Patierno SR, Sakuramoto T, Landolph JR. (1989). Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ Mol Mutagen 14:65-78.
82. Moulin JJ, Clavel T, Roy D, Danache B, Marquis N, Fevotte J, Fontana JM. (2000). Risk of lung cancer in workers producing stainless steel and metallic alloys. Int Arch Occup Environ Health 73:171-180.
83. Moulin JJ, Portefaix P, Wild P, Mur JM, Smagghe G., Mantout B. (1990). Mortality study among workers producing ferroalloys and stainless steel in France. Br J Ind Med 47(8):537-543.
84. National Toxicology Program (NTP). (1996a). Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Bethesda MD: U.S. DHHS. NTP Technical Report 454. NIH Publication No. 96-3370.
85. National Toxicology Program (NTP). (1996b). Toxicology and Carcinogenesis Studies of Nickel Subsulfde (CAS No. 12035-72-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Bethesda, MD: U.S. DHHS. NTP Technical ReportTR 453. NIH Publication No. 96-3369.
86. National Toxicology Program (NTP). (1996c). Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Bethesda MD: U.S. DHHS. NTP Technical ReportTR 451. NIH Publication No. 96-3367.
87. National Toxicology Program (NTP). (1998). Toxicology and Carcinogenesis Studies of Cobalt Sulfate Heptahydrate (CAS No. 10026-24-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). U.S. DHHS. NTP Technical Report 471. NIH Publication No. 98-3961.
88. Oberdörster G. (1989). Dosimetric principles for extrapolating results of rat inhalation studies to humans, using an inhaled Ni compound as an example. Health Phys 57:213-220.
89. Oller AR. (2002). Respiratory carcinogenicity assessment of soluble nickel compounds. Environ Health Perspect 110(Suppl. 5):841-844.
90. Oller AR, Capellini D, Henderson R, Bates HK. (2009). Comparison of nickel release in solutions used for the identifcation of water-soluble nickel exposures and in synthetic lung fuids. J Environ Monit 11:823-829.
91. Oller AR, Costa M, Oberdörster G. (1997). Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol 143:152-166.
92. Oller AR, Kirkpatrick DT, Radovsky A, Bates HK. (2008). Inhalation carcinogenicity study with nickel metal powder in Wistar rats. Toxicol Appl Pharmacol 233:262-275.
93. Oller AR, Oberdörster G. (2010). Incorporation of particle size diferences between animal studies and human workplace aerosols for deriving exposure limit values. Regul Toxicol Pharmacol 57:181-194.
94. Ottolenghi AD, Haseman JK, Payne WW, Falk HL, MacFarland HN. (1975). Inhalation studies of nickel sulfde in pulmonary carcinogenesis of rats. J Natl Cancer Inst 54(5):1165-1172.
95. Ozaki K, Haseman JK, Hailey JR, Maronpot RR, Nyska A. (2002). Association of adrenal pheochromocytoma and lung pathology in inhalation studies with particulate compounds in the male F344 rat - the National Toxicology Program experience. Toxicol Pathol 30:263-270.
96. Pang D, Burges DC, Sorahan T. (1996). Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945- 1993. Occup Environ Med 53:714-717.
97. Pott F, Rippe RM, Roller M, Csicsaky M, Rosenbruch M, Huth F. (1992). Carcinogenicity of nickel compounds and nickel alloys in rats by I.P. injection. In: Nieboer E, Nriagu JO, eds. Nickel and Human Health: Current Perspectives. New York,: John Wiley and Sons, 491-502.
98. Refsvik T, Andreassen T. (1995). Surface binding and uptake of nickel(II) in human epithelial kidney cells: Modulation by ionomycin, nicardipine and metals. Carcinogen 16(5):1107-1112.
99. Revie RW, Uhlig HH. (2008). Corrosion and Corrosion Control. Fourth 4th edition. Hoboken, NJ,: Wiley-Interscience.
100. Saito K, Menzel DB. (1986). Accumulation and efux of nickel from cultured pneumocytes. Tohoku J Exp Med 148(3):295-302.
101. Schwerdtle T, Hartwig A. (2006). Bioavailability and genotoxicity of soluble and particulate nickel compounds in cultured human lung cells. Mat-wiss U Werkstoftech 37(6):521-525.
102. Seilkop SK, Oller AR. (2003). Respiratory cancer risks associated with low-level nickel exposure: An integrated assessment based on animal, epidemiological, and mechanistic data. Regul Toxicol Pharmacol 37:173-190.
103. Sen P, Costa M. (1985). Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: Preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles. Cancer Res 45(5):2320-2325.
104. Sen P, Costa M. (1986). Pathway of nickel uptake infuences its interaction with heterochromatic DNA. Toxicol Appl Pharmacol 84(2):278-285.
105. Sivulka DJ. (2005). Assessment of respiratory carcinogenicity associated with exposure to metallic nickel: A review. Regul Toxicol Pharmacol 43:117-133.
106. Sivulka DJ, Conard BR, Hall GW, Vincent JH. (2007). Species-specifc inhalable exposures in the nickel industry: A new approach for deriving inhalation occupational exposure limits. Regul Toxicol Pharmacol 48:19-34.
107. Sivulka DJ, Selikop SK. (2009). Reconstruction of historical exposures in the U.S. nickel alloy industry and the implications for carcinogenic hazard and risk assessments. Regul Toxicol Pharmacol 53:174-185.
108. Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice JM, Younes M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34:146-152.
109. Sorahan T. (2004). Mortality of workers at a plant manufacturing nickel alloys, 1958-2000. Occup Med (Lond) 54(1):28-34.
110. Sorahan T, Burges DC, Waterhouse JAH. (1987). A mortality study of nickel/chromium platers. Br J Ind Med 44(4):250-258.
111. Sorahan T, Williams SP. (2005). Mortality of workers at a nickel carbonyl refnery, 1958-2000. Occup Environ Med 62:80-85.
112. Stopford W, Turner J, Cappellini D, Brock T. (2003). Bioaccessibility testing of cobalt compounds. J Environ Monit 5:675-680.
113. Sunderman FW, Hopfer SM, Knight JA, McCully KS, Cecutti AG, Tornhill PG, Conway K, Miller C, Patierno SR, Costa M. (1987). Physiochemical characteristics and biological efects of nickel oxides. Carcinogen 8(2):305-313.
114. Sunderman FW, Hopfer SM, Plowman MC, Knight JA. (1990). Carcinogenesis bioassays of nickel oxides and nickel-copper oxides by intramuscular administration to Fischer-344 rats. Res Commun Chem Pathol Pharmacol 70(1):103-113.
115. Sunderman FW, Maenza RM. (1976). Comparisons of carcinogenicities of nickel compounds in rats. Res. Commun Chem Pathol Pharmacol 14:319-330.
116. Sutherland RB. (1959). Summary of Report on Respiratory Cancer Mortality 1930-1957. Port Colborne, Ontario, Canada. International Nickel Company (INCO) of Canada, Ltd.
117. Svensson BG, Englander V, Akesson B, Attewell R, Skerfving S, Ericson A, Moller T. (1989). Deaths and tumors among workers grinding stainless steel. Am J Ind Med 15(1):51-59.
118. Tanaka I, Horie A, Haratake J, Kodama Y, Tsuchiya K. (1988). Lung burden of green nickel oxide aerosol and histopathological fndings in rats after continuous inhalation. Biol Trace Elem Res 16(1):19-26.
119. Tanaka I, Ishimatsu S, Matsuno K, Kodama Y, Tsuchiya K. (1995). Biological half time of deposited nickel oxide aerosol in rat lung by inhalation. Biol Trace Elem Res 8:203-210.
120. Toxicology Excellence for Risk Assessment (TERA) (1999). Toxicological Review of Soluble Nickel Salts. Prepared for Metal Finishing Association of Southern California, Inc.; US EPA; Health Canada. [Online] Available at: http:www.tera.org/vera/Nickel%20 Doc%20page.htm. Accessed on 04 October 2010.
121. US EPA. (1986). Health Assessment Document for Nickel and Nickel Compounds (Final). Washington, DC: US EPA, Ofce of Health and Environmental Assessment (Washington, DC). EPA-600/8-83-012FF. 438 pp.
122. US EPA. (2005). Guidelines for Carcinogen Risk Assessment (Final). EPA/630/P-03/001B. [Online] Available at: http://cfpub.epa. gov/ncea/cfm/ recordisplay.cfm?deid = 116283. Accessed on 04 October 2010.
123. Valentine R, Fisher GL. (1984). Pulmonary clearance of intratracheally administered 63Ni3S2 in strain A/J mice. Environ Res 34: 328-334.
124. Wehner AP, Dagle GE, Busch RH. (1984). Pathogenicity of inhaled nickel compounds in hamsters. IARC Sci. Publ. 53:143-51.
125. WIL. (2004). A 13-week Inhalation Toxicity Study (with Recovery) of Nickel Metal in Albino Rats. Study number WIL-437002. Ashland, OH: WIL Research Laboratories, Inc., Ashland, OH.
126. World Health Organization (WHO). (1991). Environmental Health Criteria 108: Nickel. Report to World Health Organization (WHO) (Geneva, Switzerland); United Nations Environment Programme; International Labour Organisation. Environmental Health Criteria 108. 383 pp.
127. Yu CP, Hsieh TH, Oller AR, Oberdörster G. (2001). Evaluation of the human nickel retention model with workplace data. Reg Toxicol Pharmacol 33:165-72.
128. Zatka VJ, Warner JS, Maskery D. (1992). Chemical speciation of nickel in airborne dusts: Analytical method and results of an interlaboratory test program. Environ Sci Technol 26:138-144.